BTEC 2012 Meeting

The Brain Tumor Epidemiology Consortium (BTEC) is an open scientific forum organized to foster the development of multi-center, international and inter-disciplinary collaborations that will lead to a better understanding of the etiology, outcomes, and prevention of brain tumors.

BTEC announces the 2012 Annual Conference: Opportunities, Challenges and Future Directions. The meeting will take place on June 30 - July 3, 2012 in Montpellier, France.

The registration is open. Forms for registration and abstract submissions (due March 1) are available here: BTEC 2012 Meeting Registration Form (revised)

Junior Investigator Awards are available. Registration (all meals included): Early bird before March 15: $475 or 375€ and after March 15: $525 or 425€.

Annual Report to the Nation

The recently published Annual Report to the Nation features incidence, mortality, and survival of malignant and non-malignant primary brain and other nervous system tumors. Please see the NAACCR website for further information (www.naaccr.org/DataandPublications/ARN.aspx).

Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LAG, Eheman C, Jemal A, Anderson RA, Ajani UA, Edwards BK. Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System. J Natl Cancer Inst 2011;103:1–23

New Statistical Report

The Central Brain Tumor Registry of the United States (CBTRUS) announces the publication of its latest statistical report, CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007 (available online at www.cbtrus.org). Data collected by the National Program of Cancer Registries (CDC) and SEER (NCI) from 48 population-based cancer registries were analyzed resulting in an incidence rate of 19.3 cases per 100,000 person-years for all primary brain & central nervous system (CNS) tumors. CBTRUS estimates that 64,530 new cases of primary non-malignant and malignant brain and CNS tumors are expected to be diagnosed in the United States in 2011. Meningioma had the highest incidence and accounted for 34% of all primary brain tumors in 2004-2007. Gliomas, including glioblastoma, accounted for 31% of these tumors and 80% of all malignant brain tumors.

Recently published

CBTRUS investigators collaborated with Dr. John Villano from the University of Illinois Medical Center on two recently published manuscripts. The first investigated non-pineal germ cell tumors, resulting in the publication of ‘Descriptive Epidemiology of Central Nervous System Germ Cell Tumors: Non-Pineal Analysis’ in Neuro-Oncology 12:257-64, 2010. The second investigated selected olfactory tumors, resulting in the publication of ‘Descriptive Epidemiology of Selected Olfactory Tumors’ in Journal of Neuro-Oncology Feb. 13, 2010. [Epub ahead of print].